Goji berry effects on macular characteristics and plasma antioxidant levels - PubMed (original) (raw)
Randomized Controlled Trial
Goji berry effects on macular characteristics and plasma antioxidant levels
Peter Bucheli et al. Optom Vis Sci. 2011 Feb.
Abstract
Purpose: Goji berry (Lycium barbarum L.) is purported to benefit vision because of its high antioxidant (especially zeaxanthin) content, although this effect has not been demonstrated in high-quality human studies. The purpose of this study was to evaluate the effects of daily supplementation with a proprietary milk-based formulation of goji berry, Lacto-Wolfberry (LWB), on macular characteristics and plasma zeaxanthin and antioxidant capacity levels in elderly subjects.
Methods: This was a double-masked, randomized, placebo-controlled trial in healthy elderly subjects (range, 65 to 70 years) receiving 13.7 g/d of LWB (n = 75) or placebo (n = 75) for 90 days. Subjects underwent direct ophthalmic examination to assess pigmentation and soft drusen count in the macula and a blood draw to measure plasma zeaxanthin level and total antioxidant capacity.
Results: The placebo group demonstrated hypopigmentation and soft drusen accumulation in the macula, whereas the LWB group remained stable. Both plasma zeaxanthin level and antioxidant capacity increased significantly in the LWB group, by 26% and 57%, respectively, but did not change in the placebo group. No product-related adverse events were reported in either group.
Conclusions: Overall, daily dietary supplementation with goji berry for 90 days increases plasma zeaxanthin and antioxidant levels as well as protects from hypopigmentation and soft drusen accumulation in the macula of elderly subjects. However, the mechanism of action is unclear, given the lack of relationship between change in plasma zeaxanthin and change in macular characteristics.
Similar articles
- Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults.
Amagase H, Sun B, Borek C. Amagase H, et al. Nutr Res. 2009 Jan;29(1):19-25. doi: 10.1016/j.nutres.2008.11.005. Nutr Res. 2009. PMID: 19185773 Clinical Trial. - Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial.
Cheng CY, Chung WY, Szeto YT, Benzie IF. Cheng CY, et al. Br J Nutr. 2005 Jan;93(1):123-30. doi: 10.1079/bjn20041284. Br J Nutr. 2005. PMID: 15705234 Clinical Trial. - Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity.
Potterat O. Potterat O. Planta Med. 2010 Jan;76(1):7-19. doi: 10.1055/s-0029-1186218. Epub 2009 Oct 20. Planta Med. 2010. PMID: 19844860 Review. - [Nutrition and age-related macular degeneration].
Desmettre T, Lecerf JM, Souied EH. Desmettre T, et al. J Fr Ophtalmol. 2004 Nov;27(9 Pt 2):3S38-56. J Fr Ophtalmol. 2004. PMID: 15602406 Review. French.
Cited by
- Therapeutic effects of herbal medicines in different types of retinopathies: A systematic review.
Ansari-Mohseni N, Ghorani-Azam A, Mohajeri SA. Ansari-Mohseni N, et al. Avicenna J Phytomed. 2023 Mar-Apr;13(2):118-142. doi: 10.22038/AJP.2022.62423.2977. Avicenna J Phytomed. 2023. PMID: 37333471 Free PMC article. Review. - Distinct Role of Lycium barbarum L. Polysaccharides in Oxidative Stress-Related Ocular Diseases.
Niu Y, Zhang G, Sun X, He S, Dou G. Niu Y, et al. Pharmaceuticals (Basel). 2023 Jan 31;16(2):215. doi: 10.3390/ph16020215. Pharmaceuticals (Basel). 2023. PMID: 37259363 Free PMC article. Review. - Health Benefits and Applications of Goji Berries in Functional Food Products Development: A Review.
Vidović BB, Milinčić DD, Marčetić MD, Djuriš JD, Ilić TD, Kostić AŽ, Pešić MB. Vidović BB, et al. Antioxidants (Basel). 2022 Jan 27;11(2):248. doi: 10.3390/antiox11020248. Antioxidants (Basel). 2022. PMID: 35204130 Free PMC article. Review. - Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.
Wong KH, Nam HY, Lew SY, Naidu M, David P, Kamalden TA, Hadie SNH, Lim LW. Wong KH, et al. Pharmaceuticals (Basel). 2022 Jan 14;15(1):101. doi: 10.3390/ph15010101. Pharmaceuticals (Basel). 2022. PMID: 35056157 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical